查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1791631

全球DNA与基因克隆服务市场

DNA and Gene Cloning Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 178 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球 DNA 和基因克隆服务市场规模将达到 78 亿美元

全球DNA和基因克隆服务市场规模预计在2024年为31亿美元，预计到2030年将达到78亿美元，2024年至2030年的复合年增长率为16.5%。基因合成服务是本报告分析的细分市场之一，预计其复合年增长率将达到18.0%，到分析期结束时将达到37亿美元。客製化克隆服务细分市场在分析期间内的复合年增长率预计为13.5%。

美国市场规模估计为 8.222 亿美元，中国市场预计复合年增长率为 15.4%

美国DNA和基因克隆服务市场规模预计在2024年达到8.222亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到12亿美元，在2024-2030年的分析期间内，复合年增长率为15.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为15.4%和14.1%。在欧洲，预计德国市场的复合年增长率为11.9%。

全球 DNA 和基因克隆服务市场 - 主要趋势和驱动因素摘要

合成生物学作用的不断扩大是否会增加克隆服务的需求？

合成生物学正迅速崛起，成为一个变革性领域，推动着生物技术、医疗保健和工业领域的空前创新。这项变革的核心是 DNA 和基因克隆服务，它们是操纵遗传物质以设计新生物系统和产品的重要工具。客製化基因合成、载体建构和质体克隆的需求日益增长，这与合成生物学在下一代疗法、疫苗、诊断方法和生物基材料开发中的应用日益广泛密切相关。在药物研发领域，基因克隆被广泛用于表达治疗性蛋白质、研究基因功能和建立疾病模型。此外，包括 COVID-19 大流行在内的近期全球健康趋势凸显了快速基因工程对于疫苗开发的重要性，使 DNA 和基因克隆成为人们关注的焦点。克隆服务使研究人员能够高精度地复製特定的 DNA 序列，对于大规模生产重组蛋白和单株抗体至关重要。随着学术机构、生技公司和委外研发机构(CRO) 之间的合作日益增多，将克隆服务外包给拥有先进分子生物学能力的专业供应商的趋势日益明显。这些供应商提供从基因设计到检验的一体化解决方案，简化了研究流程并降低了技术门槛。此外，克隆试剂套件、自动化工具和线上设计平台的出现，拓宽了非专业实验室的使用管道，使基因编辑技术的使用更加民主化。 CRISPR-Cas 系统和基因组工程的创新步伐日益加快，进一步加速了对高保真克隆服务的需求，以支持基因敲入、敲除和诱变研究，这使得 DNA 和基因克隆成为未来生物技术的核心。

技术进步是否使克隆过程更有效率和准确？

分子生物学和基因组学的技术进步显着提高了 DNA 和基因克隆服务的效率、准确性和扩充性。传统的涉及限制性内切酶和连接酶的方法已发展成为更特异性的技术，例如 Gibson 组装、Golden Gate 克隆和定点突变，从而可以实现更快、更无缝的 DNA 组装。这些技术可以将基因序列精确地插入载体，减少克隆错误并能够建立复杂的遗传迴路。自动化是另一项重大变革。高通量机器人系统现在能够以惊人的速度和可重复性执行重复性克隆任务，使服务提供者能够在短的周转时间内提供大量客製化的 DNA 构建体。结合即时PCR和次世代定序(NGS)检验，这些系统可确保整个克隆工作流程的高品质控制。人工智慧也在扩大其作用，特别是在优化基因序列以在各种宿主生物（如大肠桿菌、酵母和哺乳动物细胞）中表达方面。 AI 演算法分析密码子使用、mRNA 结构和 GC 含量，以提高翻译效率和蛋白质产量。此外，载体设计方面的创新，例如可诱导、多克隆和组织特异性表达系统的开发，扩展了基因克隆在治疗、农业和工业领域应用的多功能性。云端基础的计划管理和 LIMS 平台实现了客户和服务供应商之间的无缝沟通，提高了透明度、可追溯性和资料共用。这些技术飞跃不仅改善了研究成果，而且还帮助研究机构满足严格的监管和品质标准，特别是对于克隆基因的临床和商业级应用。随着对精准生物技术的需求不断增长，这些尖端工具的整合继续为 DNA 和基因克隆服务设定新的性能基准。

转向外包和客製化的转变会重新定义服务交付模式吗？

随着生物技术和製药研究日益复杂且数据驱动，各组织正将外包视为缩短开发週期和获得专业知识的策略性倡议。 DNA和基因克隆服务处于这一外包趋势的前沿，企业更倾向于选择外部合作伙伴来完成基因合成、载体工程、表达检验和文库建构等任务。外包模式具有明显的优势，包括快速的计划週转、专业的基础设施存取和成本效益。领先的服务供应商现在提供高度可自订的解决方案，让客户可以根据长度、序列、标籤、表达系统甚至密码子优化偏好来指定基因构建体。这种程度的客製化得益于先进的生物资讯平台，这些平台可在合成开始前协助进行基因设计、错误检查和最佳化。此外，下游应用和服务（例如蛋白质表现、纯化和功能分析）通常会捆绑在一起，从而从单一来源提供端到端的分子生物学解决方案。由于克隆的基因序列通常是对创新流程至关重要的专有讯息，因此智慧财产权保护和保密性也变得越来越重要。为了应对这项挑战，企业正在实施严格的资料安全通讯协定，例如基于区块链的样本追踪和序列加密传输。越来越多的服务供应商，尤其是在包括中国和印度在内的亚太地区，正在提供既经济高效又不影响品质的选择，进一步促进竞争和创新。学术机构也越来越多地与商业供应商合作，以便为大型合作计划提供大规模克隆服务。这种服务交付方式的转变不仅优化了研究效率，也使DNA和基因克隆成为更广泛的生命科学生态系统中重要的外包服务。

推动 DNA 和基因克隆服务市场发展的关键成长要素有哪些？

DNA 和基因克隆服务市场的成长受到与技术进步、研究多样化以及生物技术和生命科学领域消费行为变化直接相关的多种因素的驱动。一个关键驱动因素是合成生物学、免疫疗法、疫苗开发和农业生物技术等领域基因研究范围的不断扩大，这些领域都严重依赖基因克隆来创建用于实验和治疗用途的功能性构建体。 CRISPR-Cas9 和 TALEN 等基因编辑技术的广泛应用进一步推动了对精准克隆服务的需求，以支持基因改造，无论是用于疾病建模还是功能性基因筛检。同时，生物製药管线中单株抗体、细胞疗法和重组蛋白的兴起，对透过克隆建构的可靠表现系统产生了持续的需求。另一个关键驱动因素是生命科学的分散化趋势。中小型企业 (SME)、学术衍生企业和独立实验室正在承担更雄心勃勃的计划，但通常缺乏完成复杂克隆任务的内部能力，因此转向专业服务供应商。全球个别化医疗和标靶治疗的发展也刺激了针对个别患者特征和特定适应症客製化基因构建体的需求。此外，用于筛检药物标靶、酵素和结合域的合成基因库的开发，正在将克隆服务的效用扩展到传统研究应用之外。自动化高通量系统、人工智慧主导的序列设计和先进的载体系统等技术推动因素正在提高扩充性和可靠性，使提供者能够为具有复杂需求的更多不同类型的客户提供服务。最后，国际合作、研究津贴和政府支持的基因组计画正在为分子生物学基础设施注入大量资金，为持续的市场扩张创造了肥沃的土壤。这些共同的力量不仅拓宽了市场基础，而且还牢固地确立了 DNA 和基因克隆服务作为现代生物科学创新基本组成部分的地位。

部分

服务（基因合成服务、客製化克隆服务、亚克隆服务、其他服务）、应用（DNA定序、诱变、基因分型、其他应用）、最终用途（学术和研究机构、製药和生物技术公司、CMO和CRO）

受访公司范例

  • abm Inc.（Applied Biological Materials）
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio BV
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies（IDT）
  • Invitrogen（Thermo Fisher Scientific）
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP30555

Global DNA and Gene Cloning Services Market to Reach US$7.8 Billion by 2030

The global market for DNA and Gene Cloning Services estimated at US$3.1 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Gene Synthesis Service, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Custom Cloning Service segment is estimated at 13.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$822.2 Million While China is Forecast to Grow at 15.4% CAGR

The DNA and Gene Cloning Services market in the U.S. is estimated at US$822.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 15.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.

Global DNA and Gene Cloning Services Market - Key Trends & Drivers Summarized

Is the Expanding Role of Synthetic Biology Elevating the Demand for Cloning Services?

Synthetic biology has rapidly emerged as a transformative field, driving unprecedented innovation across biotechnology, healthcare, and industrial sectors. At the heart of this movement lies DNA and gene cloning services, which have become essential tools for manipulating genetic material to design novel biological systems and products. The rising demand for custom gene synthesis, vector construction, and plasmid cloning is closely tied to the growing applications of synthetic biology in developing next-generation therapeutics, vaccines, diagnostics, and bio-based materials. In pharmaceutical R&D, gene cloning is used extensively to express therapeutic proteins, study gene function, and engineer disease models. Moreover, in the wake of recent global health challenges, including the COVID-19 pandemic, the importance of rapid genetic engineering for vaccine development has pushed DNA and gene cloning into the spotlight. Cloning services enable researchers to replicate specific DNA sequences with high precision, which is vital for producing recombinant proteins and monoclonal antibodies at scale. The growing collaboration between academic institutions, biotech firms, and contract research organizations (CROs) has led to a steady outsourcing trend, where cloning services are provided by specialized vendors with advanced molecular biology capabilities. These vendors offer integrated solutions-from gene design to expression validation-streamlining research timelines and reducing technical barriers. Additionally, the availability of cloning kits, automation tools, and online design platforms is expanding access to non-specialist labs, democratizing the use of gene editing technologies. The increasing pace of innovation in CRISPR-Cas systems and genome engineering is further accelerating demand for high-fidelity cloning services that support gene knock-ins, knockouts, and mutagenesis studies, making DNA and gene cloning central to the future of bioengineering.

Are Technological Advancements Enhancing the Efficiency and Precision of Cloning Processes?

Technological advancements in molecular biology and genomics are significantly enhancing the efficiency, accuracy, and scalability of DNA and gene cloning services. Traditional methods involving restriction enzymes and ligases have evolved into more sophisticated techniques such as Gibson Assembly, Golden Gate cloning, and site-directed mutagenesis, enabling faster and more seamless DNA assembly. These techniques allow for the precise insertion of genetic sequences into vectors, reducing cloning errors and enabling the construction of complex genetic circuits. Automation is another major game-changer-high-throughput robotic systems now perform repetitive cloning tasks with remarkable speed and reproducibility, allowing service providers to deliver large volumes of customized DNA constructs within short turnaround times. Coupled with real-time PCR and next-generation sequencing (NGS) validation, these systems ensure high-quality control across the cloning workflow. Artificial intelligence is also playing a growing role, particularly in gene sequence optimization for expression in various host organisms, such as E. coli, yeast, or mammalian cells. AI algorithms analyze codon usage, mRNA structure, and GC content to improve translation efficiency and protein yield. Furthermore, innovations in vector design-such as the development of inducible, multi-cloning, and tissue-specific expression systems-have expanded the versatility of gene cloning applications across therapeutic, agricultural, and industrial domains. Cloud-based project management and LIMS platforms now allow seamless communication between clients and service providers, improving transparency, traceability, and data sharing. These technological leaps are not only improving research output but also helping institutions meet rigorous regulatory and quality standards, particularly in clinical and commercial-grade applications of cloned genes. As the demand for precision biotechnology rises, the integration of these cutting-edge tools continues to set new performance benchmarks for DNA and gene cloning services.

Is the Shift Toward Outsourcing and Customization Redefining Service Delivery Models?

As biotechnology and pharmaceutical research becomes increasingly complex and data-driven, organizations are turning to outsourcing as a strategic move to accelerate development timelines and access specialized expertise. DNA and gene cloning services are at the forefront of this outsourcing trend, with companies preferring external partners for tasks such as gene synthesis, vector engineering, expression validation, and library construction. The outsourcing model offers clear advantages: faster project turnaround, access to specialized infrastructure, and cost efficiency-especially for smaller labs and startups with limited in-house capabilities. Leading service providers now offer highly customizable solutions, where clients can specify gene constructs based on length, sequence, tags, expression systems, and even codon optimization preferences. This level of customization is supported by advanced bioinformatics platforms that assist in gene design, error checking, and optimization before synthesis begins. Additionally, services are often bundled with downstream applications such as protein expression, purification, and functional assays, providing end-to-end molecular biology solutions under one roof. There is also a growing emphasis on IP protection and confidentiality, as cloned genetic sequences often represent proprietary information critical to innovation pipelines. Companies are responding by implementing stringent data security protocols, including blockchain-based sample tracking and encrypted sequence delivery. Global expansion of service providers, particularly in Asia-Pacific regions like China and India, is driving cost-effective options without compromising quality, further intensifying competition and innovation. Academic institutions, too, are increasingly partnering with commercial providers to access cloning services at scale for large collaborative projects. This shift in service delivery is not only optimizing research productivity but is also establishing DNA and gene cloning as a critical outsourced utility in the broader life sciences ecosystem.

What Are the Main Growth Accelerators Fueling the DNA and Gene Cloning Services Market?

The growth in the DNA and gene cloning services market is driven by several factors directly linked to technological progression, research diversification, and shifting consumer behavior in biotech and life sciences. One of the primary accelerators is the expanding scope of genetic research in fields such as synthetic biology, immunotherapy, vaccine development, and agricultural biotech, all of which rely heavily on gene cloning to create functional constructs for experimental and therapeutic use. The widespread adoption of gene editing technologies like CRISPR-Cas9 and TALEN has further increased the need for precise cloning services to support genetic modifications, whether for disease modeling or functional gene screening. In parallel, the rise of monoclonal antibodies, cell-based therapies, and recombinant proteins in biopharmaceutical pipelines is generating sustained demand for reliable expression systems constructed through cloning. Another significant factor is the trend toward decentralization in life sciences, where small and mid-sized enterprises (SMEs), academic spin-offs, and independent research labs are taking on more ambitious projects, yet often lack the in-house capabilities for complex cloning tasks-thus turning to specialized service providers. The global movement toward personalized medicine and targeted therapies is also fueling demand for custom gene constructs tailored to individual patient profiles or niche indications. Moreover, the development of synthetic gene libraries for screening drug targets, enzymes, or binding domains is expanding the utility of cloning services beyond traditional research applications. Technological enablers such as automated high-throughput systems, AI-driven sequence design, and advanced vector systems are improving scalability and reliability, allowing providers to serve a more diverse clientele with complex requirements. Finally, international collaborations, research grants, and government-backed genomic initiatives are injecting substantial funding into molecular biology infrastructure, creating fertile ground for sustained market expansion. These collective forces are not only broadening the market base but are solidifying DNA and gene cloning services as a fundamental component of modern bioscience innovation.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Cloning Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service, Other Services); Application (DNA Sequencing Application, Mutagenesis Application, Genotyping Application, Other Applications); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, CMOs & CROs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • abm Inc. (Applied Biological Materials)
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio B.V.
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies (IDT)
  • Invitrogen (Thermo Fisher Scientific)
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DNA and Gene Cloning Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology Research Throws the Spotlight on Scalable DNA and Gene Cloning Solutions
    • Expanding Use of Gene Cloning in Drug Discovery and Development Propels Growth in Service Demand
    • Rise of Personalized and Targeted Therapies Strengthens Business Case for Customized Gene Constructs
    • Proliferation of CRISPR and Genome Editing Applications Drives Adoption of High-Precision Cloning Services
    • Increasing Outsourcing by Biopharma and Academic Institutions Expands Addressable Market for Specialized Providers
    • Integration of AI and Bioinformatics in Gene Design Accelerates Demand for Intelligent Cloning Platforms
    • Growth of Monoclonal Antibody and Recombinant Protein Production Spurs Demand for Expression-Ready Clones
    • Emergence of High-Throughput and Automated Cloning Workflows Enhances Operational Efficiency and Scalability
    • Adoption of Cloud-Based Platforms for Sequence Management Drives Digital Transformation in Cloning Services
    • Surge in Synthetic Gene Library Construction Generates Opportunities in Functional Genomics and Screening
    • Rising Interest in Rare Disease Research and Orphan Drug Development Spurs Need for Specialized Cloning Capabilities
    • Expansion of Agri-Biotech and Industrial Biotech Pipelines Propels Demand Beyond Traditional Life Sciences Sectors
    • Emphasis on Data Security, IP Protection, and Confidentiality Enhances Trust in Third-Party Gene Cloning Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA and Gene Cloning Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Gene Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Gene Synthesis Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Custom Cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Custom Cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sub-cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Sub-cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for DNA Sequencing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for DNA Sequencing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Mutagenesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Mutagenesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Genotyping Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION